Federico Mingozzi

Federico Mingozzi is an expert in AAV immunology and has made fundamental contributions to understanding immune responses to gene therapy vectors. His research has been instrumental in developing strategies to overcome pre-existing immunity to AAV and managing immune responses in clinical trials. Mingozzi's work has been particularly impactful for liver-directed gene therapy in hemophilia, contributing to the development of approved gene therapies.

Federico Mingozzi是AAV免疫学专家，在理解基因治疗载体免疫反应方面做出了基础性贡献。他的研究在开发克服AAV预存免疫力和管理临床试验免疫反应策略方面发挥了重要作用。Mingozzi的工作对血友病肝脏定向基因治疗产生了特别重要的影响，促进了已获批基因治疗药物的开发。